Immunodominance and tumor escape

Seminars in Cancer Biology
Hans SchreiberW M Kast

Abstract

Cancers in mouse and man express multiple tumor-specific as well as tumor-associated antigens. Immunodominance in the host response to these antigens can result in successive selection of heritable antigen loss variants. Immunodominance may also prevent the development of responses to new tumor-specific antigens that may arise during tumor progression. Some tumor-specific antigens are retained during tumor progression possibly because they are essential for survival of the malignant phenotype. Immunodominance may allow cancer cells to escape even after loss of a single MHC Class I allele because cross-presentation of the retained antigen by this allele that must be expressed on the surrounding antigen presenting cells sustains the immunodominant response. This prevents effective responses to secondary antigens that may remain as potential targets. Immunization with in vitro selected cancer cell variants that lack the immunodominant antigen can break the immunodominance and prevent escape of cancers from host immunity.

References

Oct 1, 1976·Science·P C Nowell
Jan 1, 1992·The Journal of Experimental Medicine·S SinghH Schreiber
Nov 1, 1985·The Journal of Experimental Medicine·C A MullenH Schreiber
Feb 1, 1984·European Journal of Immunology·J L UrbanH Schreiber
Apr 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·R D WortzelH Schreiber
Jan 1, 1982·Immunogenetics·P J Wettstein, D W Bailey
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·P G CoulieT Boon
Mar 1, 1996·The Journal of Experimental Medicine·P F RobbinsS A Rosenberg
Aug 29, 1997·The Journal of Experimental Medicine·S MandruzzatoP van der Bruggen
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·R C FieldsJ J Mulé
Dec 29, 1998·Immunology Today·F Ruiz-Cabello, F Garrido
Jun 15, 2000·Immunological Investigations·E RanieriW J Storkus

❮ Previous
Next ❯

Citations

Oct 31, 2002·Nature Immunology·Hung T Khong, Nicholas P Restifo
Apr 20, 2006·Nature Reviews. Immunology·Luca GattinoniNicholas P Restifo
Apr 12, 2006·The Journal of Experimental Medicine·Ilona KryczekWeiping Zou
Apr 7, 2010·Annual Review of Physical Chemistry·Arup K Chakraborty, Andrej Kosmrlj
Aug 2, 2008·Breast Cancer Research : BCR·Brian J MorrisonJ Alejandro Lopez
Jun 29, 2005·Proceedings of the National Academy of Sciences of the United States of America·Nicole ComtesseEckart Meese
Apr 13, 2006·Expert Review of Vaccines·Dexin ZhangDaiming Fan
May 19, 2006·Expert Opinion on Biological Therapy·Alberto Pinzon-CharryJosé Alejandro López
Jul 23, 2004·Expert Opinion on Biological Therapy·Birgit C Schultes, Christopher F Nicodemus
Sep 6, 2008·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·R AbbasJ Sanabria
Oct 28, 2008·Seminars in Immunology·Michelle A NellerChristopher W Schmidt
Jun 30, 2006·Thoracic Surgery Clinics·Kartik KrishnanLee J Helman
Dec 18, 2013·Bioelectrochemistry·Gaëlle VandermeulenVéronique Préat
May 25, 2005·Cancer Letters·Barbara L F KaplanMichael I Nishimura
Jan 10, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anthony E ZamoraPaul G Thomas
Mar 7, 2018·Proceedings of the National Academy of Sciences of the United States of America·Ling ChenLieping Chen
Jan 4, 2018·Nature Communications·Mirjana EfremovaZlatko Trajanoski
May 5, 2005·Current Treatment Options in Oncology·Mark B Faries, Brian J Czerniecki
Sep 14, 2007·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Shigeharu KimuraToshihiko Yamashita
Oct 4, 2005·The Cancer Journal·Kartik KrishnanLee J Helman
May 27, 2008·Nature Reviews. Immunology·Weiping Zou, Lieping Chen
Apr 11, 2020·Head & Neck·Maxwell Y Lee, Clint T Allen
Jan 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shari A PilonWei-Zen Wei
Dec 5, 2008·Expert Review of Vaccines·Lina ZhaoDaiming Fan
Feb 25, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Niels SchaftGerold Schuler
Jul 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Pavel OtahalTodd D Schell
Aug 11, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elizabeth W NewcombSilvia C Formenti
Oct 29, 2020·Journal of the Royal Society, Interface·Guim Aguadé-Gorgorió, Ricard Solé
Mar 13, 2021·Seminars in Cancer Biology·Rupen DesaiGavin P Dunn
Jun 4, 2021·Molecular Immunology·M L M JongsmaR M Spaapen
Sep 2, 2021·Annual Review of Biomedical Data Science·Andrea CastroHannah Carter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.